Stocks and Investing
Stocks and Investing
Wed, March 10, 2021
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
Oren Livnat Maintained (AVDL) at Strong Buy with Increased Target to $17 on, Mar 10th, 2021
Oren Livnat of HC Wainwright & Co., Maintained "Avadel Pharmaceuticals plc" (AVDL) at Strong Buy with Increased Target from $15 to $17 on, Mar 10th, 2021.
Oren, nor any peers, have made any analyst calls on AVDL in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources